BioWorld Asia

Sep. 27, 2006

Merck KGaA Buying Serono, Giving CHF16.6B Valuation

Merck KGaA agreed to acquire a controlling stake in Serono SA by purchasing the Bertarelli family's shares in the company, which represent 64.5 percent of its equity and 75.5 percent of its voting rights. (BioWorld International) Read More

GPC Biotech Shares Jump On Prostate Cancer Study Results

Proteomics Approach Could Bring Rapid Dipstick For TB

Another European Agenda For Innovative Medicines

Jerini Shares Plummet On Mixed Phase III Trial News

India's Avesthagen Seeking VC Money, Eyeing 2008 IPO

BioAlliance Pharma Reports Phase I/II Doxorubicin Data

Europe Trails U.S. In Tech Transfer; Patents Lag, Too

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for June 26, 2026.

Have brain-computer interfaces finally arrived?

BioWorld

More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...

News in brief

BioWorld Asia

BioWorld Asia briefs for June 23, 2026

Brain-computer interfaces are here but long road ahead

BioWorld

The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...

2026 marks critical turning point for BCI technology

BioWorld

Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...